Epharmix's Incubator/Accelerator - III Round

Epharmix raised a round of funding on December 14, 2017. Investors include MassChallenge.

Epharmix offers Condition-Specific Digital Interventions that improve clinical outcomes. The company's EpxWound is a proactive system to identify signs of early wound infection prior to the first clin…

Articles about Epharmix's Incubator/Accelerator - III Round: